Ag(I) Ag(III) O | |
| Names | |
|---|---|
| IUPAC name silver(I,III) Oxide | |
| Other names tetrasilver tetroxide, silver peroxide, argentic oxide, silver suboxide, divasil | |
| Identifiers | |
| |
3D model (JSmol) | |
| ChemSpider | |
| ECHA InfoCard | 100.013.726 |
| EC Number |
|
PubChem CID | |
| UNII | |
| |
| |
| Properties | |
| Ag4O4 Ag2O.Ag2O3 | |
| Molar mass | 123.87 g/mol |
| Appearance | grey-black powder diamagnetic |
| Density | 7.48 g/cm3 |
| Melting point | >100 °C, decomposition |
| .0027 g/100 mL | |
| Solubility | soluble in alkalis |
| Hazards | |
| GHS labelling: | |
| | |
| Danger | |
| H272, H315, H319, H335 | |
| NFPA 704 (fire diamond) | |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). | |
Silver(I,III) oxide or tetrasilver tetroxide is the inorganic compound with the formula Ag4O4. It is a component of silver zinc batteries. It can be prepared by the slow addition of a silver(I) salt to a persulfate solution e.g. AgNO3 to a Na2S2O8 solution. [1] It adopts an unusual structure, being a mixed-valence compound. [2] It is a dark brown solid that decomposes with evolution of O2 in water. It dissolves in concentrated nitric acid to give brown solutions containing the Ag2+ ion. [3]
Although its empirical formula, AgO, suggests that the compound tetrasilver tetraoxide has silver in the +2 oxidation state, each unit has two monovalent silver atoms bonded to an oxygen atom, and two trivalent silver atoms bonded to three oxygen atoms, and it is in fact diamagnetic. X-ray diffraction studies show that the silver atoms adopt two different coordination environments, one having two collinear oxide neighbours and the other four coplanar oxide neighbours. [1] tetrasilver tetraoxide is therefore formulated as AgIAgIIIO2 [4] or Ag2O·Ag2O3. It has previously been called silver peroxide, which is incorrect since it does not contain the peroxide ion, O22−.
Tetrasilver tetroxide has been marketed under a trade name "Tetrasil." In 2010, the FDA issued a warning letter to an American company concerning the firm's marketing of Tetrasil and Genisil ointments of tetrasilver tetroxide for herpes and similar conditions. [5]